| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 30.657 | 51.345 | 59.520 | 62.445 | 91.118 | 129.987 | 122.601 | 117.174 | 126.019 |
| Total Income - EUR | - | 30.657 | 51.739 | 59.692 | 62.445 | 91.293 | 130.667 | 122.601 | 117.174 | 126.282 |
| Total Expenses - EUR | - | 509 | 2.489 | 3.757 | 7.172 | 9.809 | 30.998 | 25.979 | 25.817 | 37.949 |
| Gross Profit/Loss - EUR | - | 30.147 | 49.250 | 55.935 | 55.273 | 81.484 | 99.669 | 96.623 | 91.356 | 88.333 |
| Net Profit/Loss - EUR | - | 29.228 | 47.698 | 54.145 | 53.400 | 78.740 | 95.769 | 92.945 | 90.185 | 84.545 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Auroragyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 116 | 114 | 0 | 0 | 39.922 | 33.334 | 27.144 | 20.383 | 12.566 |
| Current Assets | - | 30.051 | 49.652 | 56.316 | 55.994 | 42.460 | 87.824 | 123.885 | 132.695 | 230.305 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 2.894 | 4.821 | 378 | 3.663 | 5.332 | 41.619 | 1.040 | 93 |
| Cash | - | 30.051 | 46.759 | 51.495 | 55.616 | 38.797 | 82.493 | 82.266 | 131.655 | 230.213 |
| Shareholders Funds | - | 29.272 | 47.750 | 54.196 | 53.450 | 78.949 | 119.770 | 94.728 | 148.236 | 231.952 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 895 | 2.016 | 2.120 | 2.544 | 3.433 | 1.388 | 56.302 | 4.842 | 10.919 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Auroragyn Srl